Alex Goldberg

MannKind Corp. (NASDAQ:MNKD) and Celgene Corporation (NASDAQ:CELG) Added to Equity Profile Report's NASDAQ Decliners Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 06/18/2013 -- Equity Profile Report expands its NASDAQ Decliners Weekly Watch List adding MannKind Corp. (NASDAQ:MNKD) and Celgene Corporation (NASDAQ:CELG).

MannKind Corp. (NASDAQ:MNKD) a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States closed down in its previous session (-2.20%) on 9,834,289 shares traded after MannKind Completed Phase 3 Clinical Study of AFREZZA in Patients with Type 2 Diabetes. MannKind Corp. (NASDAQ:MNKD) is currently down (-6.95%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about MannKind Corp. (NASDAQ:MNKD)

Celgene Corporation (NASDAQ:CELG) a biopharmaceutical company that discovers, develops, and commercializes therapies for the treatment of cancer and immune-inflammatory related diseases in the United States, Europe, and other countries closed down in its previous session (-1.39%) on 2,220,051 shares traded after Celgene received EC approval for oral anti-cancer therapy REVLIMID now indicated as a treatment for patients with rare form of blood disease. Celgene Corporation (NASDAQ:CELG) is currently down (-10.45%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Celgene Corporation (NASDAQ:CELG)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com